Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 5 | 2024 | 515 | 2.150 |
Why?
|
| Glioblastoma | 3 | 2025 | 350 | 1.990 |
Why?
|
| Brain Neoplasms | 5 | 2025 | 1324 | 1.630 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2025 | 1171 | 1.100 |
Why?
|
| Immunoglobulins | 2 | 2024 | 174 | 0.930 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2025 | 78 | 0.930 |
Why?
|
| Exosomes | 1 | 2024 | 46 | 0.850 |
Why?
|
| Antigens, CD | 1 | 2024 | 431 | 0.800 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 414 | 0.780 |
Why?
|
| Astrocytoma | 1 | 2022 | 106 | 0.730 |
Why?
|
| Liver Transplantation | 4 | 2022 | 1077 | 0.720 |
Why?
|
| Hypernatremia | 1 | 2021 | 29 | 0.710 |
Why?
|
| Hyponatremia | 1 | 2021 | 73 | 0.690 |
Why?
|
| Disease Progression | 1 | 2024 | 2103 | 0.600 |
Why?
|
| MicroRNAs | 1 | 2024 | 868 | 0.540 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 3449 | 0.270 |
Why?
|
| Immune Tolerance | 1 | 2024 | 146 | 0.220 |
Why?
|
| Mutation | 4 | 2025 | 5965 | 0.210 |
Why?
|
| Pedicle Screws | 1 | 2022 | 4 | 0.200 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2022 | 24 | 0.200 |
Why?
|
| Olivary Nucleus | 1 | 2022 | 11 | 0.200 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 57 | 0.200 |
Why?
|
| Cerebellar Nuclei | 1 | 2022 | 15 | 0.200 |
Why?
|
| Graft Survival | 2 | 2022 | 540 | 0.190 |
Why?
|
| Hypertrophy | 1 | 2022 | 104 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3622 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 408 | 0.190 |
Why?
|
| Meningioma | 1 | 2023 | 119 | 0.190 |
Why?
|
| Spinal Fusion | 1 | 2022 | 113 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 306 | 0.180 |
Why?
|
| HEK293 Cells | 1 | 2024 | 746 | 0.180 |
Why?
|
| Humans | 14 | 2025 | 126330 | 0.180 |
Why?
|
| Action Potentials | 1 | 2024 | 507 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 247 | 0.180 |
Why?
|
| Meningeal Neoplasms | 1 | 2023 | 194 | 0.180 |
Why?
|
| Sodium | 1 | 2021 | 296 | 0.170 |
Why?
|
| End Stage Liver Disease | 1 | 2022 | 194 | 0.170 |
Why?
|
| Mice | 3 | 2024 | 17881 | 0.150 |
Why?
|
| Cytokines | 1 | 2024 | 1306 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 558 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 1987 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 658 | 0.120 |
Why?
|
| Animals | 3 | 2024 | 34533 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 949 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2022 | 16517 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 890 | 0.100 |
Why?
|
| Adult | 2 | 2025 | 29802 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1334 | 0.100 |
Why?
|
| Risk Factors | 2 | 2021 | 10375 | 0.080 |
Why?
|
| Male | 3 | 2025 | 62031 | 0.080 |
Why?
|
| Aged | 1 | 2025 | 19962 | 0.070 |
Why?
|
| Genomics | 2 | 2024 | 1538 | 0.060 |
Why?
|
| Middle Aged | 1 | 2025 | 27031 | 0.060 |
Why?
|
| Electrophysiological Phenomena | 1 | 2024 | 67 | 0.060 |
Why?
|
| GABAergic Neurons | 1 | 2024 | 63 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2023 | 27 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2023 | 68 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2022 | 66 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 111 | 0.050 |
Why?
|
| Potassium | 1 | 2023 | 282 | 0.050 |
Why?
|
| Living Donors | 1 | 2022 | 116 | 0.050 |
Why?
|
| Protective Factors | 1 | 2021 | 85 | 0.040 |
Why?
|
| Female | 2 | 2025 | 67333 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2022 | 239 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 230 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 1380 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1073 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 1013 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 873 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 1050 | 0.040 |
Why?
|
| Survival Rate | 1 | 2022 | 2070 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1193 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1812 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2022 | 14221 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2023 | 1551 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2835 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 2933 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 6175 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5204 | 0.020 |
Why?
|
| Child | 2 | 2022 | 24766 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3034 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8308 | 0.020 |
Why?
|
| United States | 1 | 2022 | 10990 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 12681 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12380 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 19548 | 0.010 |
Why?
|